Skip to main content
. Author manuscript; available in PMC: 2021 Oct 30.
Published in final edited form as: Am J Nephrol. 2020 Oct 30;51(11):891–902. doi: 10.1159/000511260

Table 1a:

General characteristics of each group at 6 weeks (immediately prior to treatment, n=7/group).

Normal RVD RVD+KTP-ELP-VEGF
Body weight (kg) 45.6 ± 1.1 44.8 ± 1.4 46.6 ± 2.5
Mean arterial pressure (mm Hg) 111.7 ± 2.1 131.8 ± 8.0* 132.4 ± 6.7*
Renal artery stenosis (%) 0 70 ± 7.4* 71.3 ± 3.4*
Cortical perfusion (mL/min/cc tissue) 3.9 ± 0.3 3.2 ± 0.6* 3.1 ± 0.1*
Medullary perfusion (mL/min/cc tissue) 1.8 ± 0.3 1.9 ± 0.6 1.85 ±0.4
RVR (mm Hg/mL per min) 0.31 ± 0.05 0.60 ± 0.12* 0.66 ± 0.07*
Renal volume (cc) 124.7 ± 8.3 69.3 ± 6.4* 82.0 ± 3.4*

Values are expressed as mean ± SEM. Renal vascular resistance (RVR) was quantified as mean systolic blood pressure divided by renal blood flow.

*

p<0.05 vs normal

p<0.05 vs untreated RVD